Dermatologists are ideally suited to manage the various cutaneous sequelae of graft-versus-
host disease (GVHD) outlined in part I of this review. However, the complexity of the patient …

Despite the use of high-resolution molecular techniques for tissue typing, chronic graft-
versus-host disease (cGVHD) remains a major complication following allogeneic …

Known in part since antiquity, the salutary effects of sunlight again garnered increasing
attention in the second half of the 19th century. The development of a device for ultraviolet …

Herein we review current practice regarding the management of chronic graft-vs.-host
disease (cGvHD) in paediatric patients after allogeneic haematopoietic stem cell …

The skin is the outermost mechanical barrier where dynamic immune reactions take place
and is the most commonly affected site in both acute and chronic graft-versus-host disease …

Supportive therapy plays a central role in the management of cutaneous and
musculoskeletal manifestations of chronic graft‐versus‐host disease (cGVHD), either alone …

Phototherapy can be a safe and effective treatment for various skin diseases in children.
Special considerations governing the use of this treatment modality in pediatric populations …

The development of light-emitting diodes (LEDs) has led to an increase in the use of lighting
regimes within medicine particularly as a treatment for dermatological conditions. New …

Chronic graft-versus host disease (cGVHD) occurs in 30% to 70% of patients undergoing
allogeneic hematopoietic cell transplantation (HCT). Cutaneous cGVHD affects 75% of …

Skin is usually the first and most affected organ involved in graft‐versus‐host disease
(GvHD), and treatment is still a clinical challenge. Although the need for skin‐directed …